Old Web
English
Sign In
Acemap
>
authorDetail
>
Jan van Dijk
Jan van Dijk
Astellas Pharma
Pharmacokinetics
Medicine
Anesthesia
Mirabegron
Crossover study
4
Papers
89
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmacokinetics of Roxadustat After Concomitant or Time-Separated Administration in Healthy Individuals.
2021
Clinical Therapeutics
Dorien Groenendaal-van de Meent
Virginie Kerbusch
Begona Barroso-Fernandez
Martin den Adel
Jan van Dijk
Georg Golor
Marloes Schaddelee
Show All
Source
Cite
Save
Citations (2)
Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects
2018
European Journal of Drug Metabolism and Pharmacokinetics
Dorien Groenendaal-van de Meent
Martin den Adel
Jan van Dijk
Begona Barroso-Fernandez
Rachid El Galta
Georg Golor
Marloes Schaddelee
Show All
Source
Cite
Save
Citations (10)
Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives
2017
European Journal of Drug Metabolism and Pharmacokinetics
Monique Groen-Wijnberg
Jan van Dijk
Walter Krauwinkel
Virginie Kerbusch
John Meijer
Reiner Tretter
Wenhui Zhang
Marcel van Gelderen
Show All
Source
Cite
Save
Citations (10)
Pharmacokinetic Properties of Mirabegron, a β3-Adrenoceptor Agonist: Results From Two Phase I, Randomized, Multiple-Dose Studies in Healthy Young and Elderly Men and Women
2012
Clinical Therapeutics
Walter Krauwinkel
Jan van Dijk
Marloes Schaddelee
Charlotte Eltink
John Meijer
Gregory Strabach
Sjoerd van Marle
Virginie Kerbusch
Marcel van Gelderen
Show All
Source
Cite
Save
Citations (67)
1